Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lete-Cel in Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
NCT06703346Phase 2Completed
- Sponsor
- US WorldMeds
- Start
- Dec 2019
- Primary completion
- Mar 2024
- Modality
- CAR-T Cells
- Countries
- 7
01
Overview
A Phase 2 trial of letetresgene autoleucel in synovial sarcoma (SS), myxoid round cell liposarcoma (MRCLPS), sponsored by US WorldMeds. Started Dec 2019; status: completed.
02
Drugs
letetresgene autoleucel
03
Conditions
synovial sarcoma (SS)myxoid round cell liposarcoma (MRCLPS)
Beyond the preview
Go deeper on NCT06703346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06703346.